Non-Opioid Pain Therapy-Focused Semnur Pharmaceuticals Strikes $2B SPAC Deal For NASDAQ Debut

Semnur Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company (NASDAQ:SCLX), and Denali Capital Acquisition Corp. (NASDAQ:DECA), a special purpose acquisition company, signed a lett

BenzingaJul 3 10:51 ET

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently. CureVac (CVAC) and GSK (GSK) said they re

MT NewswiresJul 3 09:18 ET

Express News | Scilex Holding Pares Gain in Premarket, Last up 7.7%

ReutersJul 3 08:43 ET

Trending Stocks Today: VivoPower Shoots up 120.66% Pre-Market

July 3rd - US stocks trending pre-market: Gainers: $VivoPower(VVPR.US)$ shoots up 120.66% to $3.31 with a turnover of $51.85 million. $CNS Pharmaceuticals(CNSP.US)$ surges 93.65% to $2.44 with a turno

Moomoo NewsJul 3 08:35 ET

Express News | Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp

BenzingaJul 3 07:33 ET

Express News | Scilex Holding Shares Jump 33.1% Premarket After Co-Backed Semnur Pharmaceuticals to Go Public in a $2 Billion SPAC Deal With Denali Capital

ReutersJul 3 04:10 ET